BFM
ANRO icon

Boothbay Fund Management’s Alto Neuroscience ANRO Stock Holding History

Boothbay Fund Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.13M Hold
139,304
– – 0.04% 460
2025
Q4 		$2.48M Buy
139,304
+106,832
+329% +$1.35M 0.04% 499
2025
Q3 		$131K Hold
32,472
– – ﹤0.01% 1703
2025
Q2 		$71.4K Sell
32,472
-23,660
-42% -$56.3K ﹤0.01% 1329
2025
Q1 		$121K Sell
56,132
-46,968
-46% -$168K ﹤0.01% 1217
2024
Q4 		$436K Buy
+103,100
New +$643K 0.01% 929

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boothbay Fund Management's ANRO Position: Q1 2026 in Review

Boothbay Fund Management held its Alto Neuroscience (ANRO) position steady in Q1 2026 at 139,304 shares worth $3.13M. The position accounts for 0.04% of the portfolio, ranked #460.

Boothbay Fund Management first reported a position in ANRO in Q4 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Boothbay Fund Management held 139,304 shares of Alto Neuroscience worth $3.13M as of Q1 2026.
  • Boothbay Fund Management left its Alto Neuroscience share count unchanged in Q1 2026.
  • Alto Neuroscience made up 0.04% of Boothbay Fund Management's portfolio in Q1 2026, its #460 holding.
  • Boothbay Fund Management first reported a position in Alto Neuroscience in Q4 2024 and has held it in 6 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.